CSI Market
Sign In | Register

Medixall Group Inc (CRCX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CRCX Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Medixall Group Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
9 Months 		(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Operating Activities
Income-0.71
Depreciation & amortization0.00
Amortization of Other Assets-0.06
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Intangible Assets, Finite-lived0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Fair Value of Assets Acquired0.00
Increase Decrease In Accrued Expenses Related Parties-
Increase Decrease In Right Of Use Asset-
Common Stock Issued To Settle Legal Matter-
Amortization Of Right Of Use Lease Asset-
Operating Lease Right Of Use Asset Amortization Expense-
Gain From Forgiveness Of Note Payable-
Amortization Of Debenture Discounts0.02
Gain From Forgiveness Of Note Payable-
Amortization Of Rightofuse Operating Lease Asset-
Net Change In Rightofuse Operating Lease Asset And Liability-
Increase Decrease In Amortization Of Intellectual Property0.02
Increase Decrease In Prepaid Expenses Related Party-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.01
Accounts Payable0.34
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.60
Discontinued operations0.00
Net Cash flow from Operating Activities-1.00
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.18
Other borrowing transactions0.00
Long-term debt - borrowings0.58
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.25
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.01
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.01
Issuance Of Common Stock In Exchange For Righttouse Intellectual Property-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.02
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-1.00
Total Cash Flow0.02
4 historic quarters locked

Sign in to unlock the full Medixall Group Inc cash flow history.

Sign In Create Free Account

About Medixall Group Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: September 8, 2025
  • Source: mdxl_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001079973-25-001435

Figures are derived from filed reports and may be restated. Historical data is subject to revision.